These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35987312)

  • 1. Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
    De Filippo O; Russo C; Manai R; Borzillo I; Savoca F; Gallone G; Bruno F; Ahmad M; De Ferrari GM; D'Ascenzo F
    Int J Cardiol; 2022 Dec; 368():1-9. PubMed ID: 35987312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries.
    Choo EH; Chang K; Lee KY; Lee D; Kim JG; Ahn Y; Kim YJ; Chae SC; Cho MC; Kim CJ; Kim HS; Jeong MH;
    J Am Heart Assoc; 2019 Jul; 8(14):e011990. PubMed ID: 31284804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design.
    Nordenskjöld AM; Agewall S; Atar D; Baron T; Beltrame J; Bergström O; Erlinge D; Gale CP; López-Pais J; Jernberg T; Johansson P; Ravn-Fisher A; Reynolds HR; Somaratne JB; Tornvall P; Lindahl B
    Am Heart J; 2021 Jan; 231():96-104. PubMed ID: 33203618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease.
    Paolisso P; Bergamaschi L; Saturi G; D'Angelo EC; Magnani I; Toniolo S; Stefanizzi A; Rinaldi A; Bartoli L; Angeli F; Donati F; Rucci P; Mattioli AV; Taglieri N; Pizzi C; Galiè N
    Front Pharmacol; 2019; 10():1606. PubMed ID: 32082147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Am J Cardiovasc Drugs; 2019 Aug; 19(4):403-414. PubMed ID: 30788675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of discharge medical therapy for secondary prevention among patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) in the United States.
    Smilowitz NR; Dubner R; Hellkamp AS; Widmer RJ; Reynolds HR
    PLoS One; 2021; 16(8):e0255462. PubMed ID: 34339469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry.
    Ciliberti G; Verdoia M; Merlo M; Zilio F; Vatrano M; Bianco F; Mancone M; Zaffalon D; Bonci A; Boscutti A; Infusino F; Coiro S; Stronati G; Tritto I; Gioscia R; Dello Russo A; Fedele F; Gallina S; Cassadonte F; Ambrosio G; Bonmassari R; De Luca G; Sinagra G; Capucci A; Kaski JC; Guerra F
    Int J Cardiol; 2021 Mar; 327():9-14. PubMed ID: 33242505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction.
    Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
    Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
    Joseph J; Koka M; Aronow WS
    J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of secondary prevention medical therapy following myocardial infarction with non-obstructive coronary arteries: a Bayesian and frequentist meta-analysis.
    Samaras A; Papazoglou AS; Balomenakis C; Bekiaridou A; Moysidis DV; Rampidis GP; Kampaktsis PN; Apostolidou-Kiouti F; Haidich AB; Kassimis G; Kouskouras K; Fragakis N; Ziakas A; Vassilikos V; Giannakoulas G
    Eur Heart J Open; 2022 Nov; 2(6):oeac077. PubMed ID: 36523547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.